In patients with metabolic syndrome, the results presented by Alizaei Yousefabadi (2021) [22] demonstrate a significant reduction in TNF-α, CRP, and IL-8 but an increase in IL-10 after a 12-week follow-up period. This evidence concerns the gene CXCL8 and metabolic syndrome.